Trial Details

COMPLETED
Basic Information
Clinical ID c1713
Identifier NCT01768858
Trial Title Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Rheumatoid Arthritis|Ankylosing Spondylitis|Psoriatic Arthritis|Crohns Disease|Ulcerative Colitis|Plaque Psoriasis
Interventions DRUG: Adalimumab
Participant Information
Sponsor AbbVie
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2013-02-05
Primary Completion Date 2017-08-13
Completion Date 2017-08-13